Navigation Links
Meijer Announces Voluntary Recall for Some Meijer Brand Peanuts and Ice Cream Novelties Citing Possible Health Risk
Date:1/30/2009

GRAND RAPIDS, Mich., Jan. 30 /PRNewswire/ -- Meijer initiated a voluntary recall of two types of its Meijer Brand dry-roasted peanuts and four types of Meijer Brand ice cream novelties sold in all of its stores in Michigan, Ohio, Indiana, Illinois and Kentucky. Meijer removed all identified products from its stores and gas stations. All sell-by dates are impacted by this recall.

    Specifically, Meijer has recalled the following items:

    -- Meijer Bulk Dry Roasted Peanuts, UPC #2-18537-00000-8
    -- Markets of Meijer Dry Roasted Peanuts, UPC #7-19283-91733-1

-- Meijer Vanilla Sundae Cone w/ Peanuts (with Garfield on packaging) UPC #7-19283-74019-9

-- Meijer Vanilla Sundae Cone w/ Peanuts (without Garfield on packaging) UPC #7-19283-91235-0

-- Meijer Fudge Sundae Cone w/ Peanuts (with Garfield on packaging) UPC #7-19283-74020-5

-- Meijer Fudge Sundae Cone w/ Peanuts (without Garfield on packaging) UPC #7-19283-91245-9

Meijer has taken these steps following announcements from the products' manufacturers that they may possibly be contaminated with salmonella. While none of the Meijer brand products have been identified as contaminated or linked to any illness, Meijer has received these products from Nut Bar Company, Inc. and Fieldbrook Foods, both of which used peanuts from Peanut Corporation of America in Blakely, Georgia, which has been verified as the source of contaminated peanut products.

Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis. For more information on Salmonella, please visit the Centers for Disease Control and Prevention's Website at http://www.cdc.gov.

Meijer requests that customers who have purchased these products destroy the product or return them to any Meijer location for a full refund. If Meijer customers are unsure if they have the recalled product, they are requested to bring in the product for determination or contact the Meijer customer contact center at 800-543-3704. Consumers with questions or concerns about their health should contact their health care provider. If symptoms are present, please visit a health care provider or go to a hospital emergency room.

"The safety of our customers is always our number one priority," said Frank J. Guglielmi, director of public relations for Meijer. "Meijer has taken these precautionary steps to help protect our customers and will return this product to our stores only once it is safe for our shoppers."


'/>"/>
SOURCE Meijer
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Meijer Supercenters to Offer PetFirst Insurance in Pet Aisles
2. Meijer Pharmacies to Offer Free Pre-Natal Vitamins
3. Meijer Honored by Michigan Primary Care Association for Leadership in Promoting Health of Michigan Residents
4. Meijer and Prescription Benefit Manager 4D Team Up to Create Innovative Prescription Insurance Program
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company ... NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic ... organizations that have excellent programs for the delivery and improvement of disease management ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... families and businesses of the greater Fort Collins area, has unveiled a collaboration ... ongoing community involvement program. Donations to this worthy cause may now be made ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The American ... 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management ... who have contributed not only to the association, but also to the Health Care ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... On Wednesday, March 22, ... at 5,821.64, up 0.48%; the Dow Jones Industrial ... and the S&P 500 closed at 2,348.45, slightly ... out of nine sectors ended the day in ... on the following Medical Instruments & Supplies equities: ...
(Date:3/23/2017)... 2017 Piramal Pharma ... gibt die Ernennung von Stuart E. Needleman ... globalen Pharmazeutikkunden eine einmalige integrierte End-to-End-Serviceplattform an ... für das erfolgreiche Wachstum und die Umsetzung ... Herr Needleman dafür verantwortlich sein, alle globalen ...
(Date:3/23/2017)... 23, 2017 Merrimack Pharmaceuticals, Inc. (NASDAQ: ... patient in a Phase 1 study of MM-310 in ... encapsulates a novel taxane and targets the EphA2 receptor, ... of many major tumor types, including prostate, ovarian, bladder, ... of this study is an important step in evaluating ...
Breaking Medicine Technology: